Stock Traders Daily - How to Trade The Market

The Best ETFs of 2011: TLT, GLD, IHE, XLU

Our Strategies work regardless of market direction or economic conditions

FREE REAL TIME TRADING REPORTS
These reports, based on our technical analysis, include precise entry levels and target prices, and help investors manage risk and realize reward. Click the symbol of your choice to receive a real time update.
December 20, 2011 at 09:42 AM
BY Billy Fisher - Contributor

Our Trading Reports in this Article:

This year has been a disappointing year for most ETF investors. Nearly 80% of the 1,381 ETFs tracked by Morningstar were unable to generate positive returns in 2011. Those that were able to make advances came from some of the least likely areas of the market. Here are four of the year’s best performing non-leveraged, non-inverse ETFs.

What Downgrade?

In August, Standard & Poor’s removed the U.S. government’s AAA sovereign credit rating for the first time in history. This move actually added fuel to the advance of the iShares Barclays 20+ Year Treasury Bond Fund (NYSE:  TLT). Year-to-date, TLT has risen 30.0%.

Even though S&P expressed its dismay with Washington’s spending habits, traders have speculated that U.S. debt is a safer investment than its European counterpart offerings which have come under siege. With such few areas of the market succeeding in 2011, traders piling into long term Treasury bonds have made this fund a leader in the ETF space.

Another safe haven asset class that has worked in 2011 has been gold. Despite a recent pullback, the SPDR Gold Trust ETF (NYSE: GLD) has gained 11.9% on the year. This past week gold fell to its lowest price since late September before regaining its footing on Friday. The precious metal is in the process of wrapping up its eleventh consecutive year of gains.

Sector Stars

The pharmaceutical sector has been one of the strongest sectors of the market in 2011. The iShares Dow Jones U.S. Pharmaceutical Index Fund (NYSE: IHE) has gained 16.0% so far this year. Even with healthy advances, some of the major pharmaceutical stocks continue to trade at relatively inexpensive valuations.

The gains made by many of IHE’s top holdings have come despite a flurry of generic competition. It could be an uphill battle for many of these companies in 2012 as major patents are coming up on expiration. That being said, the sector was able to demonstrate its resilience in 2011 as it faced many of the very same headwinds.

One other sector that has been a cut above in 2011 has been the utilities space. The steady gains logged by companies in this sector has the Utilities SPDR ETF (NYSE: XLU) trading near its 52-week high. Shares of XLU have gained 10.2% year-to-date.


Read some of our Proprietary Reports with a Free Trial:

  • 2010 - The Year of the Increase - A precursor to market action in 2010
  • Top of the Market to you - Round 2 - Proves the next major top.
  • S&P historical Valuation Comparisons - Compares today's market to past environments.
  • Expect M&A to increase as revenue growth becomes tight (August 2010)

Free Trial with Silver Membership

Review the options below by rolling your mouse over them.
Select one by clicking on it. Then click the “Next Step” button.


  • 10 Day Free Trial
  • Access to our forecasting models
  • $299 per month afterwards
  • Access to our educational webinars
  • Upgrade to Platinum at any time
  • Access to our Market Analysis
  • No cost if cancelled within 10 Days
  • Review our performance records
  • Access to our stock reports
  • Access to The Investment Rate
  • Access to Trend Tracker
  • Access to our proactive strategies
  • Access to our Economic analysis
  • Support: chat, email, and phone